The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

Benzoyl peroxide (BPO) drug products, commonly used for extended periods of time to treat acne and rosacea, degrade into carcinogenic benzene when not refrigerated, a study published in the Journal of ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

Rosacea can sometimes be mistaken for acne but the two conditions are different. In rosacea, the skin is not greasy and the spots do not cause scarring. Instead, the skin may be dry, peeling and ...

If you are struggling with dry, itchy or irritated skin and cannot figure out what is causing it, your tap water may be to ...

Rosacea flare-ups that affect the eyes can also cause styes. Triggers like stress, intense physical activity, and exposure to extreme weather can cause rosacea flare-ups. Styes are caused by a ...

Rosacea is a common, chronic inflammatory skin condition primarily affecting the face that causes permanent redness and visible blood vessels on the face or sometimes on other areas of the body.

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in adults, drugmaker Journey Medical ...

(RTTNews) - Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in collaboration with Dr. Reddy's ...